Ependymoma secondary prevention

Ependymoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Differentiating Ependymoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Staging
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ependymoma secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ependymoma secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ependymoma secondary prevention
CDC on Ependymoma secondary prevention
Ependymoma secondary prevention in the news
Blogs on Ependymoma secondary prevention
Directions to Hospitals Treating Ependymoma
Risk calculators and risk factors for Ependymoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

Secondary prevention strategies following ependymoma include regular clinical assessment and neuroimaging of the brain and spinal cord.

Secondary Prevention

• Neuroimaging coupled with clinical assessment are generally recommended after treatment for ependymoma.
• MRI imaging of the brain and/or spinal cord every 3 months for the first 1 to 2 years after treatment.
• After 2 years, imaging every 6 months for the next 3 years is often undertaken.